Jérôme Lejeune Foundation Research

For Researcher

Jérôme Lejeune Foundation Research

“Nobody could say I am able to cure Down Syndrome; I am convinced that it is possible, but I do not know yet how!”
Jérôme Lejeune
Letter to an English friend, 1985

Following the way open by Professor Jerome Lejeune (1926-1994) and his  colleagues, and thanks to our private donators, the Jérôme Lejeune Foundation continues to help the research  

to try to allow people to receive the fullness of life  to which they are entitled, what we call the freedom of mind. This is a deal for us, for  our successors and their successors, summarized in  St Irenée’ sentence, « Gloria  Dei est homo vivans« .  

(Jérôme Lejeune, 1983, Académie des sciences morales et politiques Paris) 

By different actions, helped by a panel of experts through the  international Scientific Advisory Board, the Jérôme Lejeune Foundation funds  every year researchers from all countries and international research units for more than 20 years to  searching on Down syndrome and Intellectual Disabilities from genetic origin. 

Research is one of the three Jérôme Lejeune Foundation pillars (Research, Care, Advocacy). 

Ethics in conducting Research and Protection of the Life from conception to death are essential for us “To put technology  at the service of life”. (Jérôme Lejeune,1994)  

Some different funding proposals (Call for Projects, Postdoctoral application,  and  different awards for young researchers …) are proposed to internal researchers as presented within this website to reach Jérôme Lejeune’s goal and your goal. 

The proposal  could be fundamental, translational and/or clinical. The Research projects have to be focused on Down syndrome , and on other Intellectual deficiencies from genetic origin. Down syndrome is our main focus.

Clinical  Research 

Jérôme Lejeune Institute

Clinical Research is an important part of the Research, mainly conducted in association with the Institute Jérôme Lejeune. The Jérôme Lejeune Institute takes care of more than 10,000 patients.

Biobank BioJeL ®

Biological data and clinical data can be shared within an international project following internal positive review . Biological resources can also be shared through the biobank BioJeL®